Panagora Asset Management’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding FRTX
PCM
MFG
NFG
Panagora Asset Management's FRTX Position: Q1 2020 in Review
Panagora Asset Management sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q1 2020, closing a stake of 1 share.
Panagora Asset Management first reported a position in FRTX in Q2 2013 and held it in 27 quarters. The position peaked at $223K in Q3 2018. 14 funds tracked by Wall St. Rank hold FRTX as of Q1 2020.
- Panagora Asset Management reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
- Panagora Asset Management sold 1 Fresh Tracks Therapeutics, Inc. Common Stock share in Q1 2020.
- Panagora Asset Management first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q2 2013 and held it in 27 quarters.
- Panagora Asset Management's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $223K in Q3 2018.
- 14 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q1 2020.
Based on Panagora Asset Management's 13F filing for Q1 2020, filed 14 May 2020.